OWLTNYSEMeasuring & Controlling Devices, NECUS GAAP · USD

Owlet, Inc.

Owlet, Inc. develops connected pediatric health devices and software for home use, centered on wearable infant monitors, a companion mobile app, and related digital services. The company sells its products in the United States and internationally through direct-to-consumer, retail, and healthcare distribution channels.

Kysy yhtiöstä
Liikevaihto106milj. USD
+35,4 %v/v
Liikevoitto (EBIT)−8,3milj. USD
+59,1 %v/v
EBIT-marginaali−7,8%
+18,1 %-yks.v/v
Nettotulos−39,7milj. USD
−216,5 %v/v
Vapaa kassavirta−11,1milj. USD
+1,6 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−100−50050100150milj. USD2020: 75 milj. USD2020: EBIT −7,0 milj. USD20202021: 76 milj. USD2021: EBIT −56 milj. USD20212022: 69 milj. USD2022: EBIT −85 milj. USD20222023: 54 milj. USD2023: EBIT −29 milj. USD20232024: 78 milj. USD2024: EBIT −20 milj. USD20242025: 106 milj. USD2025: EBIT −8,3 milj. USD2025106−8,3
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Owlet, Inc.

Liiketoiminta

Osuus liikevaihdosta
Wearable infant monitors70 %

FDA-cleared and internationally certified home monitoring devices for infants.

Monitoring bundles and cameras15 %

Combined hardware offerings such as Dream Duo and related home monitoring products.

Subscription software10 %

Owlet360 recurring service that provides personalized health and sleep insights.

Accessories5 %

Replacement and add-on items including fabric socks and travel cases.

Asiakkaat

Owlet sells primarily to parents and caregivers of infants who want home-based monitoring, sleep information, and health-related insights. It also serves healthcare channels and medical communities that use its certified monitoring products in clinical-to-home care settings. Retail partners and digital buyers are important because the company relies on consumer demand, brand awareness, and repeat app engagement.

Parents and caregivers

Buy Dream Sock, Dream Duo, and Owlet360 to monitor infant sleep and health at home.

Retail channel consumers

Purchase through major retailers and online marketplaces for convenience and brand trust.

Healthcare and medical users

Use medically certified products in care pathways that bridge hospital and home.

International distributors

Buy and distribute products in overseas markets where regulatory clearances enable sales.

Subscription users

Pay monthly for Owlet360 to access personalized pediatric health and sleep insights.

Strategia

Owlet’s strategy is to use its FDA-cleared and internationally certified monitoring products to build trust with parents and expand its connected pediatric health platform. The company is also extending its business model through Owlet360, which adds recurring subscription revenue and deepens engagement with its installed base. International expansion and healthcare-channel adoption are important because they broaden the addressable market beyond U.S. consumer retail.

Grow the connected monitoring ecosystemKeskipitkä aikaväli

More devices and app usage increase brand loyalty and data depth.

Scale Owlet360 subscriptionsLyhyt aikaväli

Recurring revenue can improve customer lifetime value and engagement.

Expand internationally through regulatory clearancesKeskipitkä aikaväli

Approvals unlock new markets and reduce reliance on the U.S. market.

Deepen healthcare-channel adoptionPitkä aikaväli

Medical credibility can broaden use cases and support premium positioning.

Maantiede

Q1/2026

Owlet is based in the United States and sells products domestically and in more than 30 countries. Its international footprint includes Canada, Australia, the United Kingdom, the European Union, and other markets where regulatory clearances support distribution. Geography matters because product approvals, channel mix, and local consumer adoption shape where the company can sell and how quickly it can expand.

USA79 %
Other countries (US filing)13 %
UK7,8 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

Owlet depends on consumer demand, retail sell-through, and distributor performance, so inventory levels and customer payment behavior can materially affect results. The business also faces regulatory, privacy, and competitive risks because its products sit at the intersection of consumer electronics, medical devices, and digital health. As a smaller company with a limited operating history at scale, it may need external financing and must manage product, subscription, and channel execution carefully.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Liquidity and financing risk1Channel inventory and sell-through risk2Competition from larger and non-cleared rivals3Distributor and retailer credit risk4Regulatory and product clearance risk5Privacy and marketing compliance risk6
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Liquidity and financing riskVaikutus: KriittinenTodennäköisyys: Korkea

    The company may need additional capital to fund operations and growth.

    Kohdistuu: Business continuity and strategic flexibility

  2. Channel inventory and sell-through riskVaikutus: KorkeaTodennäköisyys: Korkea

    Revenue depends on retailer stocking decisions and end-demand.

    Kohdistuu: Product sales and quarterly revenue volatility

  3. Competition from larger and non-cleared rivalsVaikutus: KorkeaTodennäköisyys: Korkea

    Competitors may have more capital, broader portfolios, and reach.

    KohdistuuPricingDistributionMarket share
  4. Distributor and retailer credit riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Sales are made through intermediaries that may delay or fail to pay.

    Kohdistuu: Accounts receivable and cash collections

  5. Regulatory and product clearance riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Medical-device style products require approvals and certifications.

    KohdistuuDream SockBabySatInternational expansion
  6. Privacy and marketing compliance riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Digital acquisition depends on use of customer data and ad targeting.

    Kohdistuu: Customer acquisition and brand reputation

Kysy Clarifolta: Owlet, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition for bundled hardware and software

Different performance obligations are recognized over different periods.

Vaikutus: Affects revenue timing and quarterly comparability

Sales returns, rebates, discounts, and allowances

Management estimates reductions to revenue based on history and contracts.

Vaikutus: Affects net revenue and receivables

Deferred revenue for subscriptions

Owlet360 cash receipts may be recognized over the service period.

Vaikutus: Affects revenue deferral and future revenue visibility

Inventory valuation and excess stock reserves

Hardware businesses must estimate obsolescence and warranty-related costs.

Vaikutus: Affects cost of revenues and gross margin

Going concern assessment

Management has disclosed substantial doubt about continued operations within one year.

Vaikutus: Affects liquidity analysis and financial statement interpretation

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Insulet Corporation

PODD · Surgical & Medical Instruments & Apparatus

Outset Medical, Inc.

OM · Electromedical & Electrotherapeutic Apparatus

OBOOK Holdings Inc

OWLS · Services-Prepackaged Software

iWallet Corp

IWAL · Communications Equipment, NEC

Ibotta, Inc.

IBTA · Services-Advertising

Inogen Inc

INGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Päivitetty: 24.9.2026

Owlet, Inc. (NYSE) – Measuring & Controlling Devices, NEC | Analyysi – Clarifo